Meet the Trialist: Jeff Sharman, MD, on ELEVATE-TN
Treatment that includes acalabrutinib can improve progression-free survival in treatment-naïve patients with chronic lymphocytic leukemia.
Read More
Dissemination (Meeting Coverage)
Advancing to Phase 3 Designs for Advanced NSCLC
Dr. Reckamp co-authored a paper that addresses the need for cautious progression from phase 1 to phase 3 trials for advanced NSCLC, summarized here.
Read More
Sandwich Treatment Model Shows Promise for Mantle Cell Lymphoma
A sandwich treatment model that includes acalabrutinib and rituximab in combination with R-DHAOx chemotherapy shows encouraging results in phase 2 trial.
Read More
Inherited Retinal Diseases Often Involve Complex “Diagnostic Odyssey”
Patients with rare inherited retinal diseases often must undertake a diagnostic odyssey before receiving a correct diagnosis.
Read More
Think You Know the Latest in AAN MS Research?
Do you remember the MS research presented at AAN? Test your knowledge now and see how you rank!
Read More
Test Your Knowledge of Psoriasis Research From Fall Clinical Dermatology Conference 2023!
Do you remember the psoriasis research presented at Fall Clinical Dermatology Conference 2023? Test your knowledge now!
Read More
Depression Impacts Outcomes in Age-Related Macular Degeneration
In age-related macular degeneration, depression can directly impact patient care through loss to follow-up, cancellations, and lack of treatment adherence.
Read More
Facilitating HRQOL Changes in Patients With ALK-Positive NSCLC
At 2023 NACLC, Heather Law, MA, presented a recap of “Associations of HRQOL with daily functioning/communication with care teams in patients with ALK+ NSCLC.”
Read More
Shared Decision-Making Tool May Improve Treatment Adherence for Patients With MS
Decision support tools help patients with MS more effectively engage with their providers and adhere to their treatment.
Read More
Test Your Knowledge of eNSCLC Research Presented at ESMO!
Do you remember the eNSCLC research presented at ESMO? Test your knowledge now!
Read More
Molecular MRD Guides Transplantation for NPM1 Mut AML in First Remission
The following is a summary of “Benefit of Allogeneic Transplant in 1st Complete Remission in...
Read More
Autologous Transplant Superior to CAR-T Therapy for Patients With Large B-Cell Lymphoma
The following is a summary of “Autologous Transplant (auto-HCT) Is Associated with Improved...
Read More
Acalabrutinib Lenalidomide+Rituximab Treatment Achieves High CR Rates in Patients With Follicular Lymphoma
The following is a summary of “Addition of Acalabrutinib to Lenalidomide and Rituximab...
Read More
Interleukin Inhibitors Highly Effective for Patients With Psoriasis
April Armstrong, MD, MPH, spoke with Physician’s Weekly about the role of interleukin inhibitors, IL-17 and IL-23, in treating psoriasis.
Read More
Check Out the 65th ASH Annual Meeting Exhibit Hall
With over 275 exhibitors, the 65th ASH Annual Meeting exhibit hall is not to be missed!
Read More
Participate Virtually in the 2023 ASH Foundation Run/Walk
Sign up today for the virtual 2023 ASH Foundation Run/Walk!
Read More
Helpful Resources for Before, During & After the 65th ASH Annual Meeting
Make the most of your attendance at the 65th ASH annual meeting by utilizing these helpful resources to plan your schedule and stay informed!
Read More
Exploring the Efficacy and Safety of Acalabrutinib Treatment By Line of Therapy in CLL and/or SLL Patients
The following is a summary of “Real-World Effectiveness and Safety Outcomes of Acalabrutinib...
Read More
Real-World Characteristics, Biomarker Testing, & Adjuvant Therapy for Resected NSCLC
At 2023 NACLC, Xiaohan Hu presented “Real-World Patients Characteristics, Biomarker Testing & Adjuvant Therapy for Resected NSCLC at US Oncology Clinics, 2019-2023”
Read More
Radiation Therapy in Today’s NSCLC Era
At the 2023 NACLC, Benjamin Lok, MD, FRCPC, presented a radiation “mini-debate” focused on the “Goldie Locks Effect.”
Read More